ALVIN MENA CANTERO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HOUSTON, TX NPI 1669845822

General Payments — all program years on this page

$8,003.92

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 133
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,587.36 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $2,564.8437
Education $22.521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $2,421.5737
2022 $1,511.7332
2023 $1,483.2626
2024 $2,587.3638

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099893209 ALK-Abello, Inc $13.91 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100444533 Novo Nordisk Inc $111.28 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104315558 AstraZeneca Pharmaceuticals LP $121.82 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104351560 AstraZeneca Pharmaceuticals LP $121.82 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104505582 AstraZeneca Pharmaceuticals LP $125.01 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104559786 AstraZeneca Pharmaceuticals LP $121.82 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104594258 AstraZeneca Pharmaceuticals LP $121.86 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105235500 AstraZeneca Pharmaceuticals LP $122.07 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105562164 AstraZeneca Pharmaceuticals LP $121.86 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105674775 AstraZeneca Pharmaceuticals LP $77.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105682521 AstraZeneca Pharmaceuticals LP $121.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105706622 AstraZeneca Pharmaceuticals LP $17.71 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105845573 AstraZeneca Pharmaceuticals LP $30.34 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105869759 AstraZeneca Pharmaceuticals LP $22.52 10/23/2024 Education Undisputed 01/23/2026 View at CMS
1105889595 AstraZeneca Pharmaceuticals LP $133.04 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105901686 AstraZeneca Pharmaceuticals LP $121.84 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114342564 Regeneron Healthcare Solutions, Inc. $32.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114342566 Regeneron Healthcare Solutions, Inc. $124.98 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114342568 Regeneron Healthcare Solutions, Inc. $21.98 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114342570 Regeneron Healthcare Solutions, Inc. $34.74 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116074117 GlaxoSmithKline, LLC. $29.45 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116233478 GlaxoSmithKline, LLC. $6.95 12/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116324270 GlaxoSmithKline, LLC. $24.62 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116325614 GlaxoSmithKline, LLC. $8.85 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116415007 GlaxoSmithKline, LLC. $21.73 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116610054 GlaxoSmithKline, LLC. $19.08 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116653773 GlaxoSmithKline, LLC. $30.14 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116723449 GlaxoSmithKline, LLC. $29.07 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131161116 PFIZER INC. $89.48 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131870859 PFIZER INC. $124.98 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135488018 Lilly USA, LLC $105.27 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137791779 Takeda Pharmaceuticals U.S.A., Inc. $121.82 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900824 GENZYME CORPORATION $5.33 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900874 GENZYME CORPORATION $34.22 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900886 GENZYME CORPORATION $31.86 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900908 GENZYME CORPORATION $16.57 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900936 GENZYME CORPORATION $149.99 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139900956 GENZYME CORPORATION $17.84 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.